Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amiodarone-induced lymphocyte toxicity and mitochondrial function

S U Yasuda1, E A Sausville, J B Hutchins

  • 1Department of Pharmacology, Georgetown University Medical Center, Washington, D.C. 20007, USA.

Journal of Cardiovascular Pharmacology
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A computerized scoring system to improve assessment of heparin-induced thrombocytopenia risk.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation.

Bone marrow transplantation·2016
Same author

Medical decision support systems and therapeutics: The role of autopilots.

Clinical pharmacology and therapeutics·2015
Same author

Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the United States: an FDA perspective.

Clinical pharmacology and therapeutics·2013
Same author

It is important research, but why is it necessary?

Clinical pharmacology and therapeutics·2013
Same author

Is it possible for FDA regulatory scientists and industry scientists to work together?

Clinical pharmacology and therapeutics·2012

Amiodarone, an effective antiarrhythmic drug, causes cytotoxicity in human lymphocytes by directly damaging mitochondria. This mitochondrial toxicity, observed at low concentrations, may explain its life-threatening side effects.

Area of Science:

  • Pharmacology
  • Toxicology
  • Cell Biology

Background:

  • Amiodarone is a highly effective antiarrhythmic medication.
  • Its clinical use is limited by severe toxicities, including liver and lung damage.
  • Human lymphocytes provide a model to study amiodarone's cytotoxic mechanisms.

Purpose of the Study:

  • To investigate the cytotoxic effects of amiodarone on human lymphocytes.
  • To identify the cellular targets and mechanisms underlying amiodarone-induced toxicity.
  • To correlate cellular damage with drug concentration and exposure time.

Main Methods:

  • Cytotoxicity was assessed using a tetrazolium dye reduction assay.
  • Mitochondrial integrity was examined via electron microscopy.

Related Experiment Videos

  • Adenosine triphosphate (ATP) synthesis and lactate dehydrogenase (LDH) release were measured.
  • Cellular and drug concentrations were quantified.

    • Main Results:

    • Amiodarone demonstrated cytotoxicity in lymphocytes with a lethal dose (LD)50 of 10.0 microM.
    • Mitochondrial damage was observed at 7.3 microM amiodarone.
    • ATP synthesis reduction and LDH release correlated with cytotoxicity.
    • No extracellular adenine nucleotide accumulation was detected.

    Conclusions:

    • Amiodarone exerts a direct toxic effect on mitochondria at concentrations below 10 microM.
    • Higher amiodarone concentrations lead to membrane damage.
    • Mitochondrial dysfunction is a key mechanism in amiodarone-induced cytotoxicity.